Skip to main content
Premium Trial:

Request an Annual Quote

Wendy Britten

Congenica has named Wendy Britton chief financial officer, effective Sept. 1. Britten joins the British clinical genomics interpretation software vendor from AstraZeneca, where she led group finance business performance. In addition to the normal CFO responsibilities, Britten will have a say in Congenica's business development and future fundraising, the company said. In announcing Britten's hiring, Congenica disclosed that it raised $13.5 million in a Series B that concluded in April 2017, higher than the $10 million reported two months earlier.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.